REGIONAL HEALTH PROPERTIES, INC (RHEPB)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 20M 40M 60M Q1 '10: 6.4M Q2 '10: 6.2M Q3 '10: 13.3M Q4 '10: 24.9M Q1 '11: 31M Q2 '11: 34.4M Q3 '11: 40.5M Q4 '11: 32.3M Q1 '12: 46.8M Q2 '12: 51.8M Q3 '12: 53.2M Q4 '12: 51.9M Q1 '13: 54.7M Q2 '13: 54.9M Q3 '13: 53.6M Q4 '13: 23.8M Q1 '14: 47.3M Q2 '14: 20.1M Q3 '14: 5.1M Q1 '15: 1.6M Q2 '15: 4.5M Q3 '15: 6.1M Q4 '15: 6.3M Q1 '16: 7.1M Q2 '16: 7.2M Q3 '16: 7.2M Q4 '16: 6.2M Q1 '17: 6.1M Q2 '17: 6.3M Q3 '17: 6.3M Q4 '17: 6.4M Q1 '18: 6M Q2 '18: 5.3M Q3 '18: 5.3M Q4 '18: 5.5M Q1 '19: 5.4M Q2 '19: 5.3M Q3 '19: 4.8M Q4 '19: 4.6M Q1 '20: 4.5M Q2 '20: 4.5M Q3 '20: 4.8M Q4 '20: 3.7M Q1 '21: 7.1M Q2 '21: 6.5M Q3 '21: 6.7M Q4 '21: 6.4M Q1 '22: 6.6M Q2 '22: 8.1M Q3 '22: 11M Q4 '22: 10.2M Q1 '23: 3.9M Q2 '23: 4.6M Q3 '23: 4.1M Q4 '23: 4.5M Q1 '24: 4.1M Q2 '24: 4.3M Q3 '24: 4.2M Q4 '24: 5.7M Q1 '25: 7.2M Q2 '25: 10.1M Q3 '25: 15.1M Q4 '25: 20.8M Q1 '26: 21.2M Q2 '26: 24.4M Q2 '10 Q3 '12 Q1 '15 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Gross Profit Quarterly

0 7M 14M 21M Q3 '25: 12.7M Q4 '25: 16.3M Q1 '26: 16.7M Q2 '26: 18.4M Q3 '25 Q4 '25 Q1 '26 Q2 '26

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income Quarterly

-7.5M -5M -2.5M 0 2.5M 5M 7.5M Q1 '10: -113.9K Q2 '10: -270.5K Q3 '10: -759.9K Q4 '10: -730.5K Q1 '11: 381K Q2 '11: 811K Q3 '11: 1.8M Q1 '12: 256K Q2 '12: 3.5M Q3 '12: 1.2M Q1 '13: -846K Q2 '13: -30K Q3 '13: 1.5M Q4 '13: -2.5M Q1 '14: 725K Q2 '14: -4.2M Q3 '14: -6.4M Q4 '14: -6.3M Q1 '15: -4M Q2 '15: -1.4M Q3 '15: 60K Q4 '15: -2.3M Q1 '16: 445K Q2 '16: 553K Q3 '16: 2M Q4 '16: 1.5M Q1 '17: 652K Q2 '17: 1.8M Q3 '17: 1.4M Q4 '17: 1.3M Q1 '18: -722K Q2 '18: -1.3M Q3 '18: 631K Q4 '18: 626K Q1 '19: 1.4M Q2 '19: 1.6M Q3 '19: 1.3M Q4 '19: 1.2M Q1 '20: 882K Q2 '20: 1.1M Q3 '20: 630K Q1 '21: 1.1M Q2 '21: 486K Q3 '21: 606K Q4 '21: 339K Q1 '22: -1.3M Q2 '22: -529K Q3 '22: -2M Q4 '22: -3M Q1 '23: -762K Q2 '23: 186K Q3 '23: -404K Q4 '23: 159K Q1 '24: -294K Q2 '24: 214K Q3 '24: -300K Q4 '24: 541K Q1 '25: -318K Q2 '25: -508K Q3 '25: -594K Q4 '25: 3.1M Q1 '26: -702K Q2 '26: -216K Q3 '11 Q1 '14 Q1 '16 Q1 '18 Q1 '20 Q2 '22 Q2 '24 Q2 '26

Net Income Quarterly

-9M -6M -3M 0 3M 6M 9M Q1 '10: 1.2M Q2 '10: -610K Q3 '10: -1.6M Q4 '10: -1.2M Q1 '11: -941K Q2 '11: -4.4M Q3 '11: 2.8M Q4 '11: -4.8M Q1 '12: -2.3M Q2 '12: -205K Q3 '12: -4.5M Q4 '12: 94K Q1 '13: -2.6M Q2 '13: -6.7M Q3 '13: -218K Q4 '13: -3.1M Q1 '14: -2.4M Q2 '14: -2.6M Q3 '14: -3.3M Q4 '14: -5.3M Q1 '15: -5M Q2 '15: -5.1M Q3 '15: -4.8M Q4 '15: -8.6M Q1 '16: -1.9M Q2 '16: -5M Q3 '16: -2M Q4 '16: -420K Q1 '17: -952K Q2 '17: 20K Q3 '17: -766K Q4 '17: -1.2M Q1 '18: -2.5M Q2 '18: -3.2M Q3 '18: -4.5M Q4 '18: -1.6M Q1 '19: 184K Q2 '19: -1.2M Q3 '19: 5.8M Q4 '19: 748K Q1 '20: -14K Q2 '20: 412K Q3 '20: -73K Q4 '20: -1M Q1 '21: 21K Q2 '21: -503K Q3 '21: -39K Q4 '21: -661K Q1 '22: -2.9M Q2 '22: -1.3M Q3 '22: -371K Q4 '22: -2.2M Q1 '23: -2M Q2 '23: -685K Q3 '23: -973K Q4 '23: -238K Q1 '24: -962K Q2 '24: -706K Q3 '24: -982K Q4 '24: -568K Q1 '25: -1.3M Q2 '25: -1.4M Q3 '25: 3.4M Q4 '25: 2.7M Q1 '26: -1.2M Q2 '26: -791K Q3 '10 Q4 '12 Q1 '15 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Cost of Revenue Quarterly

0 2.5M 5M 7.5M Q3 '25: 2.5M Q4 '25: 4.5M Q1 '26: 4.5M Q2 '26: 6.1M Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Cash Flow Quarterly

-9M -6M -3M 0 3M 6M 9M Q4 '10: -319.3K Q1 '11: 783K Q2 '11: 450K Q3 '11: -203K Q4 '11: 962K Q1 '12: 1.5M Q2 '12: -1.4M Q3 '12: 3.4M Q4 '12: -2M Q1 '13: -6.1M Q2 '13: 5.9M Q3 '13: 2.9M Q4 '13: 2.4M Q1 '14: -5.9M Q2 '14: -2.7M Q3 '14: 2.6M Q4 '14: -6.8M Q1 '15: -603K Q2 '15: -8.1M Q3 '15: -5.5M Q4 '15: -3.7M Q1 '16: -1.6M Q2 '16: 1.6M Q3 '16: -701K Q4 '16: -2.7M Q1 '17: -302K Q2 '17: 2M Q3 '17: 1.9M Q4 '17: 1.6M Q1 '18: -3K Q2 '18: 143K Q3 '18: -83K Q4 '18: 1.3M Q1 '19: -165K Q2 '19: 600K Q3 '19: 750K Q4 '19: 1.2M Q1 '20: -135K Q2 '20: 51K Q3 '20: 1M Q4 '20: 379K Q1 '21: 2.4M Q2 '21: 37K Q3 '21: 1.7M Q4 '21: 782K Q1 '22: -1.6M Q2 '22: -1.2M Q3 '22: 627K Q4 '22: -1.4M Q1 '23: 2.6M Q2 '23: 358K Q3 '23: 505K Q4 '23: 252K Q1 '24: 597K Q2 '24: 505K Q3 '24: -112K Q4 '24: 953K Q1 '25: 236K Q2 '25: 569K Q3 '25: -1.8M Q4 '25: -1.3M Q1 '26: -890K Q2 '26: 1.4M Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Free Cash Flow Quarterly

-9M -6M -3M 0 3M 6M 9M Q4 '10: -758K Q1 '11: 315K Q2 '11: -1M Q3 '11: -992K Q4 '11: -551K Q1 '12: 1M Q2 '12: -2.6M Q3 '12: 2.4M Q4 '12: -5M Q1 '13: -7.3M Q2 '13: 5.2M Q3 '13: 1.7M Q4 '13: 904K Q1 '14: -7.5M Q2 '14: -2.7M Q3 '14: 760K Q4 '14: -7.5M Q1 '15: -977K Q2 '15: -8.4M Q3 '15: -6.1M Q4 '15: -4.1M Q1 '16: -1.6M Q2 '16: 1.6M Q3 '16: -1.4M Q4 '16: -3.5M Q1 '17: -631K Q2 '17: 1.8M Q3 '17: 1.6M Q4 '17: 1.5M Q1 '18: -166K Q2 '18: 40K Q3 '18: -83K Q4 '18: 1.2M Q1 '19: -252K Q2 '19: 592K Q3 '19: 602K Q1 '20: -292K Q2 '20: 51K Q3 '20: 948K Q4 '20: 138K Q1 '21: 2.3M Q2 '21: -4K Q3 '21: 1.7M Q4 '21: 778K Q1 '22: -1.7M Q2 '22: -1.3M Q3 '22: 596K Q4 '22: -1.5M Q1 '23: 2.6M Q2 '23: -494K Q3 '23: 443K Q4 '23: 210K Q1 '24: 542K Q2 '24: 165K Q3 '24: -147K Q4 '24: 853K Q1 '25: 171K Q2 '25: 274K Q3 '25: -2.1M Q4 '25: -1.5M Q1 '26: -1.3M Q2 '26: 889K Q1 '12 Q1 '14 Q1 '16 Q1 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 7M 14M 21M Q2 '10: 5.7M Q3 '10: 8.3M Q1 '11: 8.8M Q2 '11: 8.8M Q3 '11: 13.3M Q1 '12: 12.2M Q2 '12: 13.5M Q3 '12: 14.5M Q1 '13: 14.7M Q2 '13: 14.8M Q3 '13: 15M Q1 '14: 16.9M Q2 '14: 17.2M Q3 '14: 18.1M Q1 '15: 19.2M Q2 '15: 19.8M Q3 '15: 19.8M Q1 '16: 19.9M Q2 '16: 19.9M Q3 '16: 19.9M Q1 '17: 19.8M Q2 '17: 19.8M Q3 '17: 19.8M Q1 '18: 1.6M Q2 '18: 1.7M Q3 '18: 1.7M Q1 '19: 1.7M Q2 '19: 1.7M Q3 '19: 1.7M Q1 '20: 1.7M Q1 '21: 1.7M Q2 '21: 1.7M Q3 '21: 1.8M Q1 '22: 1.8M Q2 '22: 1.8M Q3 '22: 1.8M Q1 '23: 1.9M Q2 '23: 1.9M Q3 '23: 1.9M Q1 '24: 1.8M Q2 '24: 1.8K Q3 '24: 1.9K Q1 '25: 2M Q2 '25: 2.1M Q3 '25: 3.1K Q1 '26: 3.9M Q2 '26: 3.9M Q3 '11 Q3 '13 Q3 '15 Q3 '17 Q3 '19 Q2 '22 Q2 '24 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-15.00 -10.00 -5.00 0.00 5.00 10.00 15.00 Q4 '10: -0.38 Q1 '11: -0.51 Q2 '11: -0.90 Q3 '11: -0.45 Q4 '11: -0.74 Q1 '12: -0.84 Q2 '12: -0.35 Q3 '12: -0.93 Q4 '12: -0.51 Q1 '13: -0.52 Q2 '13: -0.98 Q3 '13: -0.70 Q4 '13: -0.94 Q1 '14: -0.92 Q2 '14: -0.64 Q3 '14: -0.83 Q4 '14: -0.91 Q1 '15: -1.02 Q2 '15: -1.16 Q3 '15: -1.26 Q4 '15: -1.46 Q1 '16: -1.36 Q2 '16: -1.37 Q3 '16: -1.24 Q4 '16: -0.74 Q1 '17: -0.69 Q3 '18: -14.43 Q4 '18: -11.86 Q3 '11 Q3 '12 Q3 '13 Q3 '14 Q3 '15 Q3 '16 Q4 '18

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.